Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Novartis

This article was originally published in The Tan Sheet

Executive Summary

Novartis: Ciba Geigy/Sandoz merger is one step closer to completion following the approval by the European Commission, the firms announce July 17. The companies are still waiting for approval by U.S. regulatory authorities including FTC and the Justice Department; "substantial progress has been achieved with the FTC," Ciba and Sandoz noted. The firms announced their intention to merge on March 7 ("The Tan Sheet" March 11, p. 1). Fred Huser, current Sandoz U.S. consumer pharmaceuticals president, will head Novartis' U.S. self-medication business ("The Tan Sheet" May 13, p. 6)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085613

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel